The epigenetic factor BORIS (CTCFL) controls the androgen receptor regulatory network in ovarian cancer

The identification of prognostic biomarkers is a priority for patients suffering from high-grade serous ovarian cancer (SOC), which accounts for >70% of ovarian cancer (OC) deaths. Meanwhile, borderline ovarian cancer (BOC) is a low malignancy tumor and usually patients undergo surgery with low p...

Descripción completa

Detalles Bibliográficos
Autores principales: Salgado-Albarrán, Marisol, González-Barrios, Rodrigo, Guerra-Calderas, Lissania, Alcaraz, Nicolás, Estefanía Sánchez-Correa, Thalía, Castro-Hernández, Clementina, Sánchez-Pérez, Yesennia, Aréchaga-Ocampo, Elena, García-Carrancá, Alejandro, Cantú de León, David, Herrera, Luis A., Baumbach, Jan, Soto-Reyes, Ernesto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6690894/
https://www.ncbi.nlm.nih.gov/pubmed/31406110
http://dx.doi.org/10.1038/s41389-019-0150-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6690894/
https://www.ncbi.nlm.nih.gov/pubmed/31406110
http://dx.doi.org/10.1038/s41389-019-0150-2

Ejemplares similares